134 related articles for article (PubMed ID: 20160206)
1. Frontotemporal dementia and pharmacologic interventions.
Kaye ED; Petrovic-Poljak A; Verhoeff NP; Freedman M
J Neuropsychiatry Clin Neurosci; 2010; 22(1):19-29. PubMed ID: 20160206
[TBL] [Abstract][Full Text] [Related]
2. [Rivastigmine in the treatment of dementia: from the symptomatic effect to neuroprotection].
Damulin IV
Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(9):76-82. PubMed ID: 21246897
[No Abstract] [Full Text] [Related]
3. A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease.
Di Santo SG; Prinelli F; Adorni F; Caltagirone C; Musicco M
J Alzheimers Dis; 2013; 35(2):349-61. PubMed ID: 23411693
[TBL] [Abstract][Full Text] [Related]
4. Galantamine in frontotemporal dementia and primary progressive aphasia.
Kertesz A; Morlog D; Light M; Blair M; Davidson W; Jesso S; Brashear R
Dement Geriatr Cogn Disord; 2008; 25(2):178-85. PubMed ID: 18196898
[TBL] [Abstract][Full Text] [Related]
5. [New anti-AD drugs--their possibilities and issues].
Nakamura Y
Seishin Shinkeigaku Zasshi; 2012; 114(3):255-61. PubMed ID: 22568059
[TBL] [Abstract][Full Text] [Related]
6. An open-label, comparative study of rivastigmine, donepezil and galantamine in a real-world setting.
Aguglia E; Onor ML; Saina M; Maso E
Curr Med Res Opin; 2004 Nov; 20(11):1747-52. PubMed ID: 15537474
[TBL] [Abstract][Full Text] [Related]
7. Drug therapy of dementia in elderly patients. A review.
Olsen CE; Poulsen HD; Lublin HK
Nord J Psychiatry; 2005; 59(2):71-7. PubMed ID: 16195103
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of cholinesterase inhibitors in treating the behavioural symptoms of dementia.
Rösler M
Int J Clin Pract Suppl; 2002 Jun; (127):20-36. PubMed ID: 12139365
[TBL] [Abstract][Full Text] [Related]
9. Effect of rivastigmine in the treatment of behavioral disturbances associated with dementia: review of neuropsychiatric impairment in Alzheimer's disease.
Grossberg GT
Curr Med Res Opin; 2005 Oct; 21(10):1631-9. PubMed ID: 16238903
[TBL] [Abstract][Full Text] [Related]
10. [Rivastigmine: a review of its clinical effectiveness].
Spiegel R
Rev Neurol; 2002 Nov 1-15; 35(9):859-69. PubMed ID: 12436385
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenetic mechanisms of dementia in the older patients with Parkinson's diseases].
Chukhlovina ML
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(7):79-82. PubMed ID: 25202788
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of degenerative dementia disorders--who should be treated?].
Hasselbalch SG; Kampmann JP
Ugeskr Laeger; 2009 Mar; 171(10):802-5. PubMed ID: 19265606
[TBL] [Abstract][Full Text] [Related]
13. Rivastigmine monotherapy and combination therapy with memantine in patients with moderately severe Alzheimer's disease who failed to benefit from previous cholinesterase inhibitor treatment.
Dantoine T; Auriacombe S; Sarazin M; Becker H; Pere JJ; Bourdeix I
Int J Clin Pract; 2006 Jan; 60(1):110-8. PubMed ID: 16409439
[TBL] [Abstract][Full Text] [Related]
14. Frontotemporal dementia: a review for primary care physicians.
Cardarelli R; Kertesz A; Knebl JA
Am Fam Physician; 2010 Dec; 82(11):1372-7. PubMed ID: 21121521
[TBL] [Abstract][Full Text] [Related]
15. [Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
Gasser US; Gasser T
MMW Fortschr Med; 2001 Dec; 143(51-52):40-1. PubMed ID: 11824165
[No Abstract] [Full Text] [Related]
16. Frontotemporal dementia.
Miller B; Llibre Guerra JJ
Handb Clin Neurol; 2019; 165():33-45. PubMed ID: 31727221
[TBL] [Abstract][Full Text] [Related]
17. Effects of rivastigmine on cognitive function in patients with traumatic brain injury.
Noble JM; Hauser WA
Neurology; 2007 May; 68(20):1749; author reply 1750. PubMed ID: 17502565
[No Abstract] [Full Text] [Related]
18. Cholinesterase inhibitors: tremor and exacerbation of Parkinson's disease.
Prescrire Int; 2007 Oct; 16(91):197-8. PubMed ID: 17926835
[TBL] [Abstract][Full Text] [Related]
19. [Rivastigmine in a case of autopsy proved frontotemporal dementia (Pick's disease)].
Calatayud-Noguera T; Astudillo-González A; Alvarez-Carriles JC; Temprano-Fernández T; Cortés-Velarde M; Oliva-Nacarino P
Rev Neurol; 2009 Jun 1-15; 48(11):582-4. PubMed ID: 19472156
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of current specific treatments on behavioral and psychological symptoms in patients with Alzheimer's disease: a 12-month, randomized, open-label trial.
Cumbo E; Ligori LD
J Alzheimers Dis; 2014; 39(3):477-85. PubMed ID: 24164733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
